SCHEMBL20565003

SCHEMBL20565003

Cc1ccc(S(=O)(=O)ON=C(C(=O)OC(C)C)C(=O)OC(C)C)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.40
LMNA P02545 3/20 0.40
MAPK1 P28482 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
MAPT P10636 2/20 0.40
RAB9A P51151 2/20 0.40
HSP90AA1 P07900 1/20 0.40
PKM P14618 1/20 0.40
XBP1 P17861 1/20 0.40
MPI P34949 1/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
CYP2C19 P33261 1/20 0.37
KDM4E B2RXH2 1/20 0.36
GAA P10253 2/20 0.36
GFER P55789 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26325165 0.86 ALDH1A1 (0.38) ALDH1A1LMNAMAPK1NPSR1TDP1
SCHEMBL25440168 0.83 MMP1 (0.39) MAPK1MAPTMEN1KMT2AGAA
SCHEMBL26324757 0.83 F2 (0.44) ALDH1A1LMNAMAPK1NPSR1TDP1
SCHEMBL6025288 0.82 ALDH1A1 (0.44) ALDH1A1LMNANPSR1TDP1MAPT
SCHEMBL6025287 0.82 ALDH1A1 (0.44) ALDH1A1LMNANPSR1TDP1MAPT
SCHEMBL20565357 0.81 KMT2A (0.44) ALDH1A1LMNAMAPK1NPSR1TDP1
SCHEMBL20564169 0.80 ALDH1A1 (0.44) ALDH1A1LMNAMAPK1NPSR1TDP1
SCHEMBL20564714 0.79 ALDH1A1 (0.40) ALDH1A1LMNAMAPK1NPSR1TDP1
SCHEMBL26324736 0.79 F2 (0.51) ALDH1A1LMNATDP1MAPTRAB9A
SCHEMBL25440241 0.78 MAPT (0.37) ALDH1A1LMNAMAPK1NPSR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11767291-B2 Preparation of secondary amines with electrophilic N-linchpin reagents WILLIAM MARSH RICE UNIVERSITY (US) 2023-09-26 US disclosed
US-11767291-B2 Preparation of secondary amines with electrophilic N-linchpin reagents WILLIAM MARSH RICE UNIVERSITY (US) 2023-09-26 US disclosed
US-11767291-B2 Preparation of secondary amines with electrophilic N-linchpin reagents WILLIAM MARSH RICE UNIVERSITY (US) 2023-09-26 US disclosed
WO-2018213572-A9 PREPARATION OF SECONDARY AMINES WITH ELECTROPHILIC N-LINCHPIN REAGENTS WILLIAM MARSH RICE UNIVERSITY (US) 2018-12-13 WO disclosed
WO-2018213572-A1 PREPARATION OF SECONDARY AMINES WITH ELECTROPHILIC N-LINCHPIN REAGENTS WILLIAM MARSH RICE UNIVERSITY (US) 2018-11-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11767291-B2 Preparation of secondary amines with electrophilic N-linchpin reagents PNMT, NCL, NPM1 ALDH1A1 1805/4885LMNA 167/4885MAPK1 3313/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.